Free Trial
→ The Prophet's Newest Prediction (From Stansberry Research) (Ad) Buy AMGN Stock  Free AMGN Stock Alerts

Amgen (AMGN) Short Interest Ratio & Short Volume

Amgen logo
$271.34 -3.67 (-1.33%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$271.38 +0.04 (+0.01%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Amgen Short Interest Data

Amgen (AMGN) has a short interest of 14.62 million shares, representing 2.72% of the float (the number of shares available for trading by the public). This marks a 0.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 2.79 million shares to cover all short positions.

Current Short Interest
14,620,000 shares
Previous Short Interest
14,540,000 shares
Change Vs. Previous Month
+0.55%
Dollar Volume Sold Short
$4.25 billion
Short Interest Ratio
4.7 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
537,706,000 shares
Float Size
536,600,000 shares
Short Percent of Float
2.72%
Today's Trading Volume
2,559,426 shares
Average Trading Volume
2,785,463 shares
Today's Volume Vs. Average
92%
Short Selling Amgen?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Amgen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AMGN Short Interest Over Time

AMGN Days to Cover Over Time

AMGN Percentage of Float Shorted Over Time

Amgen Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202514,620,000 shares $4.25 billion +0.6%2.7%4.7 $290.92
4/15/202514,540,000 shares $4.29 billion +3.3%2.7%4.6 $295.30
3/31/202514,080,000 shares $4.39 billion -6.5%2.6%4.3 $311.55
3/15/202515,060,000 shares $4.72 billion -6.8%2.8%4.5 $313.71
2/28/202516,160,000 shares $4.98 billion +0.5%3.0%4.8 $308.06
2/15/202516,080,000 shares $4.68 billion +26.2%3.0%4.3 $291.16
1/31/202512,740,000 shares $3.64 billion +11.5%2.4%3.3 $285.42
1/15/202511,430,000 shares $3.07 billion +2.3%2.1%3.2 $268.94
12/31/202411,170,000 shares $2.91 billion -3.1%2.1%3.4 $260.64
12/15/202411,530,000 shares $3.12 billion +3.5%2.2%3.6 $270.62
11/30/202411,140,000 shares $3.15 billion +13.6%2.1%4 $282.87
11/15/20249,810,000 shares $2.78 billion +11.2%1.8%4 $283.61
10/31/20248,820,000 shares $2.82 billion -5.9%1.6%4.8 $320.16
10/15/20249,370,000 shares $3.05 billion -4.5%1.8%4.9 $325.09
9/30/20249,810,000 shares $3.16 billion +9.0%1.8%5 $322.21
9/15/20249,000,000 shares $2.99 billion +6.1%1.7%4.5 $332.45
8/31/20248,480,000 shares $2.83 billion -8.2%1.6%4.1 $333.83
8/15/20249,240,000 shares $3.01 billion -5.6%1.7%4.3 $325.39
7/31/20249,790,000 shares $3.25 billion +2.2%1.8%4.3 $332.47
7/15/20249,580,000 shares $3.16 billion +6.7%1.8%3.9 $330.15
6/30/20248,980,000 shares $2.81 billion -1.5%1.7%3.6 $312.45
6/15/20249,120,000 shares $2.72 billion +0.8%1.7%3.6 $298.62
5/31/20249,050,000 shares $2.77 billion -11.7%1.7%3.5 $305.85
5/15/202410,250,000 shares $3.27 billion +5.5%1.9%3.8 $319.04
4/30/20249,720,000 shares $2.66 billion -3.9%1.8%3.2 $273.94
4/15/202410,110,000 shares $2.68 billion -3.4%1.9%3.5 $265.51
3/31/202410,470,000 shares $2.98 billion -5.8%2.0%3.6 $284.32
3/15/202411,110,000 shares $2.99 billion +0.8%2.1%3.8 $268.87
2/29/202411,020,000 shares $3.02 billion -0.6%2.1%3.8 $273.83
2/15/202411,090,000 shares $3.21 billion +19.3%2.1%4 $289.07
1/31/20249,300,000 shares $2.92 billion +5.2%1.7%3.5 $314.26
1/15/20248,840,000 shares $2.71 billion -2.2%1.7%3.6 $306.51
12/31/20239,040,000 shares $2.60 billion -0.2%1.7%3.6 $288.02
12/15/20239,060,000 shares $2.50 billion +11.9%1.7%3.6 $275.45
11/30/20238,100,000 shares $2.18 billion +19.7%1.5%3.3 $269.64
11/15/20236,770,000 shares $1.85 billion +5.5%1.3%2.8 $273.03
10/31/20236,420,000 shares $1.64 billion +0.9%1.2%2.6 $255.70
10/15/20236,360,000 shares $1.81 billion -0.8%1.2%2.6 $284.10
9/30/20236,410,000 shares $1.72 billion +2.2%1.2%2.6 $268.76
9/15/20236,270,000 shares $1.63 billion +1.1%1.2%2.5 $260.72
A new financial chapter (Ad)

Porter Stansberry says what happened last week could become the defining legacy of his financial publishing career. In a special event watched by thousands, he unveiled what he calls “the boldest undertaking” he’s ever attempted — a real-money initiative that will document every trade, decision, win, and loss in pursuit of a million-dollar mission. And the results are already surprising. One early beta tester tripled her investment income in just three trades.

If you missed the event, he’s republishing the message he sent to attendees right after it ended.
8/31/20236,200,000 shares $1.59 billion -11.8%1.2%2.5 $256.34
8/15/20237,030,000 shares $1.87 billion +8.0%1.3%2.6 $266.01
7/31/20236,510,000 shares $1.52 billion -9.3%1.2%2.4 $234.15
7/15/20237,180,000 shares $1.63 billion +3.3%1.4%2.8 $227.43
6/30/20236,950,000 shares $1.54 billion -3.5%1.3%3 $222.02
6/15/20237,200,000 shares $1.64 billion -2.8%1.4%3 $228.44
5/31/20237,410,000 shares $1.64 billion -2.4%1.4%3.1 $220.65
5/15/20237,590,000 shares $1.77 billion -0.3%1.4%3.4 $233.53
4/30/20237,610,000 shares $1.82 billion -4.8%1.4%3.3 $239.74
4/15/20237,990,000 shares $2.00 billion +2.0%1.5%3.3 $250.00
3/31/20237,830,000 shares $1.89 billion +2.9%1.5%3.1 $241.75
3/15/20237,610,000 shares $1.79 billion +3.3%1.4%3.2 $234.90
2/28/20237,370,000 shares $1.71 billion -0.9%1.4%2.9 $231.66
2/15/20237,440,000 shares $1.79 billion -5.8%1.4%2.9 $240.07
1/31/20237,900,000 shares $1.99 billion -10.0%1.5%2.9 $252.40
1/15/20238,780,000 shares $2.39 billion -1.6%1.7%3.3 $271.73
12/30/20228,920,000 shares $2.34 billion -5.7%1.7%3.2 $262.64
12/15/20229,460,000 shares $2.52 billion -4.7%1.8%3.3 $266.14
11/30/20229,930,000 shares $2.84 billion -4.8%1.9%3.5 $286.40
11/15/202210,430,000 shares $2.96 billion -11.4%2.0%3.7 $283.60
10/31/202211,770,000 shares $3.18 billion -30.1%2.2%4.3 $270.35
10/15/202216,840,000 shares $4.23 billion -1.6%3.2%6.4 $251.34
9/30/202217,110,000 shares $3.86 billion +0.9%3.2%6.6 $225.40
9/15/202216,950,000 shares $3.86 billion +2.6%3.2%6.4 $227.66
8/31/202216,520,000 shares $3.97 billion -0.4%N/A5.6 $240.30
8/15/202216,580,000 shares $4.16 billion -4.1%3.1%5.6 $251.08
7/31/202217,280,000 shares $4.28 billion -0.3%3.2%5.6 $247.47
7/15/202217,330,000 shares $4.31 billion +0.6%3.3%5.3 $248.69
6/30/202217,220,000 shares $4.19 billion -7.0%3.2%5.3 $243.30
6/15/202218,510,000 shares $4.36 billion -8.8%3.5%5.7 $235.58
5/31/202220,300,000 shares $5.21 billion +7.7%3.8%6.6 $256.74
5/15/202218,850,000 shares $4.59 billion -5.4%3.5%6 $243.40
4/30/202219,930,000 shares $4.65 billion -4.0%3.7%6 $233.19
4/15/202220,750,000 shares $5.27 billion -7.9%3.9%6.5 $254.02
3/31/202222,520,000 shares $5.45 billion -8.0%4.1%7.1 $241.82
3/15/202224,470,000 shares $5.67 billion -8.1%4.4%7.9 $231.56
2/28/202226,620,000 shares $6.03 billion +124.1%4.8%8.5 $226.48
2/15/202211,880,000 shares $2.66 billion +2.7%2.1%3.9 $223.94
1/31/202211,570,000 shares $2.63 billion -1.7%2.1%3.8 $227.14
1/15/202211,770,000 shares $2.77 billion -2.5%2.1%4.2 $235.36
12/31/202112,070,000 shares $2.72 billion +5.9%2.2%4.3 $224.97
12/15/202111,400,000 shares $2.50 billion -11.9%2.0%3.9 $219.25
11/30/202112,940,000 shares $2.57 billion +11.4%2.3%4.7 $198.88
11/15/202111,620,000 shares $2.41 billion -1.4%2.1%4.4 $207.40
10/29/202111,790,000 shares $2.44 billion +3.6%2.1%4.6 $206.97
10/15/202111,380,000 shares $2.37 billion +2.7%2.0%4.5 $207.84
9/30/202111,080,000 shares $2.36 billion -4.7%2.0%4.5 $212.65
9/15/202111,630,000 shares $2.54 billion +3.8%2.1%4.8 $218.13
8/31/202111,210,000 shares $2.53 billion -0.3%2.0%4.7 $225.53
8/13/202111,240,000 shares $2.58 billion +5.0%2.0%4.6 $229.68
Here’s your answer (Ad)

Porter Stansberry is stepping into the spotlight — and putting real skin in the game. For the first time ever, he’s opening the doors to a live, real-money trading account, managed transparently with the same strategies he’s used to build long-term wealth. Every 90 days, he and his lead analyst release a new tranche of trades designed for serious investors who don’t want to babysit the market. The goal: income, downside protection, and asymmetric upside.

Lance James breaks down the full FAQ on what this is (and isn’t) — including why they believe now i
7/30/202110,710,000 shares $2.59 billion +3.6%1.9%4.3 $241.54
7/15/202110,340,000 shares $2.55 billion +10.7%1.8%4 $246.63
6/30/20219,340,000 shares $2.28 billion -6.8%1.6%3.6 $243.75
6/15/202110,020,000 shares $2.40 billion -0.2%1.8%3.9 $239.85
5/28/202110,040,000 shares $2.39 billion -12.4%1.8%3.6 $237.94
5/14/202111,460,000 shares $2.89 billion +8.0%2.0%4.1 $252.07
4/30/202110,610,000 shares $2.49 billion -3.3%1.9%3.9 $234.71
4/15/202110,970,000 shares $2.74 billion -3.7%1.9%4.2 $249.62
3/31/202111,390,000 shares $2.84 billion +15.3%2.0%4.3 $249.75
3/15/20219,880,000 shares $2.28 billion +22.0%1.7%3.6 $230.36
2/26/20218,100,000 shares $1.84 billion -7.0%1.4%3.2 $227.52
2/12/20218,710,000 shares $2.05 billion +15.2%1.5%3.5 $235.04
1/29/20217,560,000 shares $1.87 billion +7.7%1.3%3 $247.75
1/15/20217,020,000 shares $1.70 billion +0.9%1.2%2.8 $241.66
12/31/20206,960,000 shares $1.58 billion +0.7%1.2%2.8 $227.17
12/15/20206,910,000 shares $1.59 billion +6.1%1.2%2.7 $229.46
11/30/20206,510,000 shares $1.46 billion -13.0%1.1%2.5 $224.81
11/15/20207,480,000 shares $1.78 billion +5.2%1.3%2.6 $237.36
10/30/20207,110,000 shares $1.55 billion +5.8%1.2%2.6 $217.82
10/15/20206,720,000 shares $1.60 billion +9.6%1.2%2.5 $237.65
9/30/20206,130,000 shares $1.56 billion -9.5%1.1%2.4 $254.16
9/15/20206,770,000 shares $1.68 billion +9.2%1.2%2.6 $248.35
8/31/20206,200,000 shares $1.57 billion +41.2%1.1%2.4 $253.32
8/14/20204,390,000 shares $1.05 billion -10.8%0.8%1.8 $239.71
7/31/20204,920,000 shares $1.20 billion -10.6%0.8%1.9 $244.67
7/15/20205,500,000 shares $1.39 billion -8.8%0.9%2 $253.31
6/30/20206,030,000 shares $1.42 billion +2.4%1.0%2.1 $235.86
6/15/20205,890,000 shares $1.29 billion -4.4%1.0%2 $219.78
5/29/20206,160,000 shares $1.41 billion -12.1%N/A1.8 $229.70

AMGN Short Interest - Frequently Asked Questions

What is Amgen's current short interest?

Short interest is the volume of Amgen shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 14,620,000 shares of AMGN short. 2.72% of Amgen's shares are currently sold short. Learn More on Amgen's current short interest.

What is a good short interest ratio for Amgen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMGN shares currently have a short interest ratio of 5.0. Learn More on Amgen's short interest ratio.

Which institutional investors are shorting Amgen?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Cubist Systematic Strategies LLC, Caption Management LLC, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, All Terrain Financial Advisors LLC, Susquehanna International Group LLP, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, ADAPT Investment Managers SA, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Maven Securities LTD, Kovitz Investment Group Partners LLC, Persistent Asset Partners Ltd, Arrowpoint Investment Partners Singapore Pte. Ltd., HighTower Advisors LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., XY Capital Ltd, Delta Accumulation LLC, Jefferies Financial Group Inc., Readystate Asset Management LP, Allianz Asset Management GmbH, Fulcrum Asset Management LLP, Insight Advisors LLC PA, and CenterStar Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Amgen?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.72% of Amgen's floating shares are currently sold short.

Is Amgen's short interest increasing or decreasing?

Amgen saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 14,620,000 shares, an increase of 0.6% from the previous total of 14,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Amgen's float size?

Amgen currently has issued a total of 537,706,000 shares. Some of Amgen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amgen currently has a public float of 536,600,000 shares.

How does Amgen's short interest compare to its competitors?

2.72% of Amgen's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Amgen: Gilead Sciences, Inc. (1.90%), Vertex Pharmaceuticals Incorporated (1.48%), Regeneron Pharmaceuticals, Inc. (2.78%), Alnylam Pharmaceuticals, Inc. (2.42%), Biogen Inc. (2.18%), United Therapeutics Co. (4.45%), Neurocrine Biosciences, Inc. (4.54%), BioMarin Pharmaceutical Inc. (2.35%), Incyte Co. (3.36%), Exelixis, Inc. (7.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Amgen stock?

Short selling AMGN is an investing strategy that aims to generate trading profit from Amgen as its price is falling. AMGN shares are trading down $3.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Amgen?

A short squeeze for Amgen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMGN, which in turn drives the price of the stock up even further.

How often is Amgen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMGN, twice per month. The most recent reporting period available is April, 30 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:AMGN) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
The Prophet's Newest Prediction
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...
Stansberry Research | Sponsored
The DOJ Just Said Your Money Isn’t Yours
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
A new financial chapter
Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...
Porter & Company | Sponsored
The Secret Map of America, Declassified…
Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...
Banyan Hill Publishing | Sponsored
Trump’s Bitcoin Reserve is No Accident…
How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...
Crypto 101 Media | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored